This Wolfe isn't in sheep's clothing
- This Wolfe isn't in sheep's clothing. // CMAJ: Canadian Medical Association Journal;3/4/2009 Doctor's Health Matters, p584
An interview with Dr. Sidney Wolfe of the consumer group United States Public Citizen is presented. When asked regarding any intellectual conflict of interest as safety committee member of the Food & Drug Administration (FDA), Wolfe states that he would not consider drug safety as a conflict. He...
- The politics of drug safety. // Multinational Monitor;Sep99, Vol. 20 Issue 9, p23
Interviews Doctor Sidney Wolfe concerning the politics of drug safety. Origins of the United States drug regulatory system; Authority of the US Food and Drug Administration; Problems from inadequate drug regulatory system.
- Q and A: Dr. Sidney Wolfe, co-founder and director of Public Citizen's Health Research Group. // Public Citizen News;Jul2011, Vol. 31 Issue 4, p10
An interview with the director of the Health Research Group of the Public Citizen organization, Sidney Wolfe is presented. When asked about his inspiration for working on danÂgerous drugs, he refers to his experiences at the National Institutes of Health (NIH) where he found that many unsafe...
- Internal Conflict. // Canada & the World Backgrounder;Sep2006, Vol. 72 Issue 1, p9
This article discusses the internal conflict within Islam. According to the author, there seems to be almost as much conflict within Islam itself as between Islam and the West. There are often violent clashes between the Sunni and Shi'ite branches playing out as a vicious civil war in Iraq....
- COI rules might delay drugs: report. M. I. // Medical Marketing & Media;Dec2010, Vol. 45 Issue 12, p18
The article focuses on the analysis of author and law professor Richard Epstein on the negative effects of conflict-of-interest (COI) rules on drugs.
- Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial. Buffel du Vaure, Céline; Boutron, Isabelle; Perrodeau, Elodie; Ravaud, Philippe // BMC Medicine;2014, Vol. 12 Issue 1, p1
Background Systematic reporting of funding sources is recommended in the CONSORT Statement for abstracts. However, no specific recommendation is related to the reporting of conflicts of interest (CoI). The objective was to compare physicians' confidence in the conclusions of abstracts of...
- ERRATUM. // Pulmonary Circulation;2012, Vol. 2 Issue 3, preceding p271
A correction to the article "Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension," that was published in the April-June 12, 2012 issue is presented.
- FDA is criticised for hinting at looser conflict of interest rules. Lenzer, Jeanne // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/13/2011, Vol. 343 Issue 7819, p338
No abstract available.
- Ethics group wants FDA to drop two tobacco panel advisers over 'conflicts'. Pecquet, Julian // Hill;6/8/2010, Vol. 17 Issue 63, p18
The article reports that good-government group Citizens for Responsibility and Ethics in Washington is urging the U.S. Food and Drug Administration to dismiss two members of its advisory panel on tobacco products for financial conflicts of interests.